Document:

exv10w1

Exhibit 10.1

EMPLOYMENT AGREEMENT

This EMPLOYMENT AGREEMENT (the “Agreement”) is made on the 5th day of May 2011 by
and between LINDSAY CORPORATION, a Delaware corporation (the “Company” or “Lindsay”) and James
Raabe (the “Executive”).

WITNESSETH:

WHEREAS, the Company desires to employ Executive as Vice President and Chief Financial
Officer; and

WHEREAS, the Company and Executive desire to obtain assurances of continued employment of
Executive for the period provided in this Agreement;

NOW, THEREFORE, in consideration of the foregoing and the mutual promises and agreements
hereinafter set forth, the Company and the Executive agree as follows:

ARTICLE I

EMPLOYMENT AND DUTIES

SECTION 1.1. Position and Responsibilities. The Company hereby employs the Executive
to render full-time exclusive services (as defined in Section SECTION 1.3 hereof) to the Company
during the Term (as hereinafter defined), subject to the direction of the President of Lindsay (the
“President”) or such other person as the President or the Board of Directors of Lindsay (the
“Board”) may designate from time to time (the President or such other person so designated, the
“Supervisor”). In such capacity and subject to such direction, the Executive shall (i) devote his
full professional time and attention, best efforts, energy and skills to the services required of
him as an employee of the Company, except for paid time off taken in accordance with the Company’s
policies and practices, and subject to the Company’s policies pertaining to reasonable periods of
absence due to sickness, personal injury or other disability; (ii) use his best efforts to promote
the interests of the Company; (iii) comply with all applicable governmental laws, rules and
regulations and with all of the Company’s policies, rules and/or regulations applicable to the
employees of the Company, including, without limitation, the Code of Business Conduct and Ethics of
the Company as amended from time to time; and (iv) discharge his responsibilities in a diligent and
faithful manner, consistent with sound business practices and in accordance with the Supervisor’s
directives. As of the date of this Agreement, the Executive is serving as the Chief Financial
Officer of the Company.

SECTION 1.2. Acceptance. The Executive hereby accepts such employment and agrees to
render the services described above in the manner described above.

SECTION 1.3. Exclusive Service. It is understood and agreed that the Executive may
not engage in other business activities during the Term, whether or not for profit or other
pecuniary advantage; provided, however, that the Executive may make financial investments which do
not involve his active participation and may engage in other activities such as participation in
charitable, educational, religious, civic and similar type organizations and similar types of
activities and, with the consent of the President, may serve as an
outside director on the board of directors of other corporations which are not affiliates or competitors of the
Company or any of its affiliates, all to the extent that such activities do not hinder or interfere
with the performance of his duties under this Agreement or conflict with the policies of Lindsay
concerning conflicts of interest or with the businesses of Lindsay or any of its affiliates in any
material way.

 

 

 

ARTICLE II

TERM

SECTION 2.1. Term. Beginning on June 13, 2011, the Executive will be employed by the
Company for a period of twelve (12) months, unless his employment is terminated at an earlier date
in accordance with ARTICLE IV (the “Term”), provided that on each date thereafter the Term shall
automatically be extended for an additional day, unless the Company notifies Executive in writing
that it does not wish to further extend the Term. Accordingly, this Agreement shall have a
remaining Term of twelve (12) months from the date when the Company notifies the Executive in
writing that it does not wish to further extend the Term. Those obligations which by their terms
survive the termination of this Agreement shall not be extinguished by the expiration of the Term
or the termination of this Agreement.

ARTICLE III

COMPENSATION

SECTION 3.1. Basic Salary. As of the date of this Agreement, the Executive’s annual
base salary (“Salary”) is $300,000. Executive’s Salary may be increased from time to time based on
merit or such other considerations as the Compensation Committee of the Board (“Compensation
Committee”) may deem appropriate, and prior to a Change in Control (as defined in Section 4.8
herein) may be reduced as part of a general across the board Salary reduction that is applicable to
all senior executives with comparable responsibility, title or stature. The Salary shall be
payable in periodic installments in accordance with the Company’s regular payroll practices as in
effect from time to time.

SECTION 3.2. Bonus; Equity Incentives. In addition to the Salary:

(a) The Executive shall be eligible to receive an annual bonus (“Bonus”), in the discretion of
the Compensation Committee, based on the performance of the Company relative to financial
objectives and the performance of the Executive relative to personal objectives, in each case as
such objectives are set forth in the Company’s annual management incentive plan. The Executive’s
target Bonus shall be 45% of his Salary beginning Fiscal 2011 (prorated from start date), subject
to change in the discretion of the Compensation Committee prior to a Change in Control.

(b) The Executive shall be eligible to receive annual performance stock units, restricted
stock units and/or other equity or long-term incentives, in the discretion of the Compensation
Committee.

SECTION 3.3. Pro-ration and Payment of Taxes. All required employment taxes,
withholding and deductions shall be deducted from the Salary and the
Bonus. If the Executive does not work any full year or this Agreement has been terminated before the end of any year,
the Salary shall be pro-rated for the period actually worked.

 

 

 

SECTION 3.4. Benefits. The Executive shall be eligible to participate in and receive
the benefits under any deferred compensation plan, health, life, accident and disability insurance
plans or programs, relocation programs and any other employee benefit or fringe benefit plans or
arrangements that the Company makes available generally to other senior executives of the Company,
pursuant to the provisions of such plans or arrangements as in effect from time to time.

SECTION 3.5. Vacations. The Executive will be entitled to vacation and sick days in
accordance with the policies of the Company for its employees generally, as in effect from time to
time. Vacation must be taken by the Executive at such time or times as reasonably approved by the
President.

SECTION 3.6. Expenses. The Company shall pay or reimburse the Executive for all
reasonable, ordinary and necessary business expenses incurred or paid by the Executive during the
Term in the performance of the Executive’s services under this Agreement in accordance with the
applicable policies and procedures of the Company as in effect from time to time, upon the
presentation of proper expense statements or such other supporting documentation as the Company may
reasonably require.

ARTICLE IV

TERMINATION OF EMPLOYMENT

SECTION 4.1. General. The Executive’s employment may be terminated by the Company
during the Term as provided in this ARTICLE IV. Upon termination of employment, the Term shall end
and the Executive shall be paid the pro-rated portion of the Salary accrued but unpaid to the date
of his termination. The Executive’s rights under the Company’s employee benefit plans shall be
determined under the provisions of such plans and/or applicable law and any payments due under such
plans shall be distributed pursuant to the provisions thereof.

SECTION 4.2. Death or Disability. The Executive’s employment hereunder shall
terminate automatically as of the date of his death, and the Company may at any time at its option,
exercised by notice to the Executive, terminate his employment for “disability” (as hereinafter
defined). In the event of termination for death or disability, the Company, subject to the
provisions of Section SECTION 4.1, shall have no further obligations or liabilities to the
Executive hereunder. For purposes of this Agreement, the term “disability” means any physical or
mental illness, disability or incapacity which, in the good faith determination of the Board,
prevents the Executive from performing the essential functions of his position hereunder for a
period of not less than ninety consecutive days (or for shorter periods totaling not less than one
hundred and twenty days) during any period of twelve consecutive months.

SECTION 4.3. Cause. The Company may, at any time, at its option, exercised by notice
to the Executive, terminate his employment for cause when cause exists. In the event of
termination for cause, the Company, subject to the provisions of Section SECTION 4.1, shall have no
further obligations or liabilities to the Executive hereunder. For
purposes of this Agreement, the term “cause” means (i) any conviction of the Executive for a felony or
misdemeanor (other than for minor motor vehicle offenses or other minor offenses); (ii) any
material breach by the Executive of this Agreement or the willful failure of the Executive to
comply with any lawful directive of the Supervisor, the President or the Board or any lawful policy
of the Company; or (iii) dishonesty or gross negligence by the Executive in the performance of his
duties hereunder.

 

 

 

SECTION 4.4. Other Than For Cause. The Company may, at any time, at its option,
terminate the employment of the Executive other than for cause, death or disability, in which event
the Company shall pay to Executive in a lump sum, within ninety (90) days of such termination, an
amount equal to one (1) times Executive’s Salary (or Executive’s Salary plus target Bonus in the
event of termination other than for cause, death or disability within one year following a Change
in Control), at the rate in effect on the date of his termination, subject to execution of the
release referred to in Section 4.6 below and the expiration of all revocation periods under
applicable law with respect to such release (and subject to continued compliance by the Executive
with ARTICLE V). This amount shall be in lieu of and shall be reduced by any termination or
severance pay representing Salary or Bonus which is payable to Executive under any Proprietary
Matters Agreement, offer of employment letter or other agreement with the Company or any of its
affiliates.

In the event the Executive voluntarily terminates his employment with the Company for Good
Reason (as defined below) at any time within one year after a Change in Control, such event shall
be considered equivalent to a termination without cause, and the Executive shall be entitled to
receive the same payment provided in the previous paragraph for termination without cause within
one year after a Change in Control. “Good Reason” will exist if: (a) Executive’s Salary, target
Bonus or total compensation opportunity (including Salary, target Bonus and long-term incentive
compensation opportunity) is reduced below the level in effect immediately prior to the Change in
Control, (b) Executive’s title, duties or responsibilities with the Company are significantly
reduced from those in effect immediately prior to the Change in Control, or (c) Executive is
required to relocate his principal office to a location more than fifty (50) miles from its
location immediately prior to the Change in Control, provided that the Executive must furnish
written notice to the Company setting forth the reasons for Executive’s intention to terminate
employment for Good Reason under this paragraph, and the Company shall have an opportunity to cure
the actions or omissions forming the basis for such intended termination, if possible, within
thirty (30) days after receipt of such written notice.

SECTION 4.5. Extension. Any extension of the Term (other than automatic extensions
under Section 2.1) must be agreed upon in writing by both parties hereto.

SECTION 4.6. Satisfaction of Liabilities. No amounts shall be payable by the Company
to the Executive under this ARTICLE IV until the Executive executes a general release in a form
reasonably acceptable to the Company. Upon the delivery of such executed general release to the
Company and subject to the Company’s compliance with Section 4.4, the Company shall have no further
liability of any kind or nature whatsoever to the Executive under this Agreement.

SECTION 4.7. Assistance to Company. The Executive agrees that in the event any
administrative or legal proceeding is instituted against the Company
or any of its affiliates in connection with any action taken while the Executive was in the Company’s employ, the
Executive will provide reasonable assistance and cooperation in defense of such action or
proceeding.

 

 

 

SECTION 4.8. Change in Control. For purposes of this Agreement, “Change in Control”
shall mean any of the following events: (a) a dissolution or liquidation of the Company, (b) a
sale of substantially all of the assets of the Company, (c) a merger or combination involving the
Company after which the owners of Common Stock of the Company immediately prior to the merger or
combination own less than 50% of the outstanding shares of common stock of the surviving
corporation, or (d) the acquisition of more than 50% of the outstanding shares of Common Stock of
the Company, whether by tender offer or otherwise, by any “person” (as such term is used in Section
13(d) and 14(d) of the Securities Exchange Act of 1934) other than a trustee or other fiduciary
holding securities under an employee benefit plan of the Company.

ARTICLE V

COVENANTS AND REPRESENTATIONS

SECTION 5.1. Proprietary Matters Agreement. The Executive acknowledges that he has
previously entered into a Proprietary Matters Agreement with the Company and agrees to comply with
and be bound by all of the provisions of the Proprietary Matters Agreement that apply to him, and
Executive agrees that the payments provided for under this Agreement shall be in lieu of and shall
be reduced by any amounts which are payable to Executive under the Proprietary Matters Agreement.

SECTION 5.2. Enforcement. If the Executive commits a material breach of any of the
provisions of the Proprietary Matters Agreement referred to in Section 5.1, the Executive shall
forfeit all rights to receive any amounts of any nature whatsoever from the Company under this
Agreement or otherwise, and the Company will be entitled to the remedies provided under the
Proprietary Matters Agreement and any other rights and remedies the Company may have pursuant to
applicable laws.

SECTION 5.3. Representation. The Executive represents and warrants to the Company
that he has full power to enter into this Agreement and perform his duties hereunder and that his
execution and delivery of this Agreement and his performance of his duties hereunder shall not
result in a breach of or constitute a default under any agreement or understanding, oral or
written, to which he is a party or by which he may be bound.

ARTICLE VI

MISCELLANEOUS

SECTION 6.1. Voluntary Nature. The Executive represents, warrants and acknowledges
that he is voluntarily agreeing to the provisions of this Agreement. The Executive has been urged
to, and hereby represents, warrants and acknowledges that he has had the opportunity to, obtain the
advice of his own attorney unrelated to the Company or any of its affiliates prior to executing and
delivering this Agreement.

 

 

 

SECTION 6.2. Notice. Any notice required or permitted to be given under this
Agreement shall be sufficient if it is in writing and is delivered in person or sent by certified
mail, return receipt to (i) his current residence, in the case of the Executive, or (ii) the
President at Lindsay’s principal corporate office, in the case of the Company. Notice shall be
deemed effective upon receipt if made by personal delivery or upon deposit in the United States
mail.

SECTION 6.3. Non-Assignability. Neither of the parties hereto shall have the right to
assign this Agreement or any rights or obligations hereunder without the prior written consent of
the other party; provided, however, that the Company may assign this Agreement without the prior
written consent of the Executive to any purchaser of the Company or of all or substantially all of
the Company’s assets, or to the surviving entity upon any merger or consolidation of the Company
with or into another entity.

SECTION 6.4. Applicable Law. This Agreement and the relationship of the parties in
connection with the subject matter of this Agreement shall be construed and enforced according to
the laws of the state of Nebraska without giving effect to the conflict of law rules thereof.

SECTION 6.5. Effect of Prior Agreements. This Agreement (together with the
Proprietary Matters Agreement) contains the full and complete agreement of the parties relating to
the employment of the Executive hereunder. This Agreement may not be amended, modified or
supplemented and no provision or requirement may be waived except by written instrument signed by
the party to be charged.

SECTION 6.6. Severability. Wherever possible, each provision of this Agreement will
be interpreted in a manner to be effective and valid, but if any provision is held invalid or
unenforceable by any court of competent jurisdiction, then such provision will be ineffective only
to the extent of such invalidity or unenforceability, without invalidating or affecting in any
manner the remainder of such provision or the other provisions of this Agreement.

SECTION 6.7. Absence of Waiver. The failure to enforce at any time any of the
provisions of this Agreement or to require at any time performance by the other party of any of the
provisions hereof shall in no way be construed to be a waiver of such provisions or to affect
either the validity of this Agreement or any part hereof or the right of either party thereafter to
enforce each and every provision in accordance with the terms of this Agreement.

SECTION 6.8. Arbitration. Any dispute, disagreement or other question arising under
this Agreement or the interpretation thereof shall be settled by final and binding arbitration
before a single arbitrator under the arbitration provisions of the Employment Dispute Resolution
Rules of the American Arbitration Association then in effect, and judgment upon the award may be
entered in any court having jurisdiction thereof.

SECTION 6.9. I.R.C. §409A. Exhibit A which is attached to this Agreement modifies and
clarifies certain terms and condition of this Agreement in order to comply with Section 409A of the
Internal Revenue Code. It is hereby incorporated by reference as part of this Agreement as if set
forth herein.

SECTION 6.10. Counterparts. This Agreement may be executed in counterparts, each of
which shall constitute one and the same instrument.

[Remainder of Page Left Blank Intentionally]

 

 

 

IN WITNESS WHEREOF, the parties have executed and delivered this agreement as of the date
first above written.

	 	 	 	 	 
	Company: 	LINDSAY CORPORATION

 	 
	 	By:  	/s/ Richard W. Parod
 	 
	 	 	Name:  	Richard W. Parod 	 
	 	 	Title:  	President and CEO 	 
	 
	 	 	 
	Executive:          	/s/ James Raabe
 	 
	 	Name: James Raabe 
	 	 	 

 

 

 

	 	 	 	 	 

EXHIBIT A TO LINDSAY CORPORATION

EMPLOYMENT AGREEMENT

I.R.C. § 409A

This Exhibit A to the Lindsay Corporation Employment Agreement (“Agreement”) modifies and
clarifies certain terms and conditions of the Employment Agreement between Lindsay Corporation
(“Company”) and the Executive (herein referred to as “Employee”). The purpose of this Exhibit A is
to comply with Section 409A of the Internal Revenue Code (“Section 409A”)

1. Termination of Employment. To the extent that the Agreement provides for any
termination payments to be made or provided to Employee as a result of involuntary termination of
employment without cause or by Employee for Good Reason, Employee will be considered to have
experienced a termination of employment when Employee has a “separation from service” within the
meaning of Section 409A.

In general, Employee will have a “separation from service” within the meaning of Section 409
as of the date that the level of bona fide services that Employee is expected to perform
permanently decreases to no more than 20% of the average level of bona fide services that Employee
performed over the immediately preceding 36-month period (or the full period of services if
Employee has been providing services less than 36 months).

For these purposes, “services” include services that Employee provides as an employee or as an
independent contractor. In addition, in determining whether Employee has experienced a “separation
from service,” the Company is obligated to take into account services Employee provides both for it
and for any other corporation that is a member of the same “controlled group” of corporations as
the Company under Section 414(b) of the Internal Revenue Code or any other trade or business (such
as a partnership) which is under common control with the Company as determined under Section 414(c)
of the Internal Revenue Code, in each case as modified by Section 409A. In general, this means
that the Company will consider services Employee provides to any corporation or other entity in
which Lindsay Corporation, directly or indirectly, possesses at least 50% of the total voting power
or at least 50% of the total value of the equity interests.

2. Release and Timing of Termination Payments. The Release which Employee is required
to deliver to the Company in order to receive termination payments under the Agreement shall be
delivered to Company not later than 30 days following Employee’s “separation from service.” Except
as provided in Paragraph 3 below, Employee’s lump sum termination payment shall be paid in full on
the first regular payday following Employee’s “separation from service” after Employee’s right to
revoke the Release pursuant to applicable law has lapsed, but in no event later than ninety (90)
days following Employee’s “separation from service.”

3. Required Delay in Payment for “Specified Employees”. Each of the payments under
this Agreement shall be considered a separate payment for purposes of Section 409A.

 

 

 

Notwithstanding any provision to the contrary in this Agreement, if (a) Employee is a “specified
employee” within the meaning of Section 409A for the period in which any payment or benefit under
this Agreement would otherwise commence or be made, and (b) such payment or benefit under this
Agreement would otherwise subject Employee to any tax, interest or penalty imposed under Section
409A if the payment or benefit were to commence or be made within six months of Employee’s
termination of employment with the Company, then all such payments or benefits that would otherwise
be paid during the first six months after Employee’s “separation from service” within the meaning
of Section 409A shall be accumulated and shall be paid on the earlier of (1) the first day which is
at least six months after Employee’s “separation from service” within the meaning of Section 409A
or (2) the date of Employee’s death.

4. Reimbursements. If Employee is entitled to receive during or following termination
of employment any reimbursements that constitute deferred compensation for purposes of Section
409A, (a) any such reimbursements shall be paid no later than the last day of the calendar year
following the calendar year in which the related expense was incurred; (b) the amounts eligible for
reimbursement in any calendar year shall not affect the amounts eligible for reimbursement in any
other calendar year, and (c) the right to reimbursement is not subject to liquidation in exchange
for any other payment or benefit.

5. No Liability of Company. Lindsay Corporation shall not be liable to Employee for
any taxes, interest or penalties which may be imposed on Employee under Section 409A or
corresponding provisions of state laws.Exhibit 10.22

Exhibit 10.22

RETIREMENT AND POST-EMPLOYMENT AGREEMENT

THIS RETIREMENT AND POST-EMPLOYMENT AGREEMENT (the “Agreement”) effective as of April 1, 2011
(the “Effective Date”) is entered into by and between Meridian Bioscience, Inc., an Ohio
corporation with a principal place of business at 3471 Riverhills Drive, Cincinnati, Ohio 45244,
USA (“Meridian”), and Antonio Alessandro Interno, an Italian citizen residing at Via dei Pini 8,
20020 Arconate, Milan, Italy (“Mr. Interno”).

RECITALS:

WHEREAS, Mr. Interno has elected, as of March 31, 2011, to retire and resign all official positions
he holds at Meridian and certain of Meridian’s European subsidiaries; and

WHEREAS, Meridian has decided to accept Mr. Interno’s retirement and resignation; and

WHEREAS, in connection with Mr. Interno’s retirement and resignation, Mr. Interno and Meridian have
agreed that Meridian will provide certain post-employment benefits to Mr. Interno, all on the terms
and conditions set forth hereinafter.

NOW THEREFORE, in reliance on the foregoing, and in consideration of the mutual covenants set forth
herein and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, Meridian and Mr. Interno agree as follows:

1. Retirement and Resignation. Mr. Interno hereby agrees to retire and
resigns, as of March 31, 2011, from all official offices and/or positions held by Mr.
Interno with respect to Meridian, and shall execute the form of resignation letter attached
hereto as Exhibit A upon execution of this Agreement.

2. Continuation of Professional Services. For a period of twenty-one (21)
months after the Effective Date, Meridian will contract with Mr. Interno, as an independent
contractor, on the conditions specified in that certain Professional Services Agreement
attached hereto as Exhibit B (the “Professional Services Agreement”). Meridian and Mr.
Interno shall execute the Professional Services Agreement upon execution of this Agreement.
Notwithstanding the above, the twenty-one (21) month period will be extended for an
additional monthly period, or portion thereof, to equal the amount, if any, that Mr. Interno
may be entitled to receive as bonus compensation under the Officer’s Performance
Compensation Plan utilizing Mr. Interno’s fiscal 2011 world-wide compensation of EUR 296,337
and a Personal Achievement multiplier of 1.0, for this fiscal year of Meridian (Fiscal Year
2011). By way of example, if Mr. Interno’s bonus compensation would be €32,500, Mr.
Interno’s Professional Services Agreement would be extended an additional five (5) months.

3. Equity Award. Mr. Interno shall receive equity awards under the terms and
conditions provided in the Meridian Bioscience, Inc. 2004 Equity Compensation Plan, as
amended and restated through January 22, 2008, for an employee under Mr. Interno’s specific
position. The provisions of section 2(a) of the November 11, 2010
Restricted Stock Unit Award Agreement-Performance Award shall control this award which
is dependent upon reaching Net Earnings of $33,400,000 for fiscal 2011.

 

 

 

4. General Release. Mr. Interno hereby releases, acquits and forever
discharges Meridian, its affiliates and their respective officers, directors, shareholders,
employees, agents, representatives, parents, subsidiaries, successors, and assigns
(“Released Parties”) from any and all causes of action, claims, suits, compensation,
demands, damages, costs, interest (statutory or common law), expenses, attorney fees and
liabilities of any kind, known or unknown, which Mr. Interno had, now has or might hereafter
have against any or all of the Released Parties arising from Mr. Interno’s employment as an
officer or any other capacity of Meridian.

Mr. Interno acknowledges and agrees (i) that Mr. Interno’s waiver of rights under this
Release is knowing and voluntary; (ii) that Mr. Interno is releasing all claims for
discrimination under federal, state and local laws, including the Age Discrimination in
Employment Act; (iii) that Mr. Interno agrees to not file a lawsuit against Meridian, and if
an administrative claim is filed by Mr. Interno or anyone else with the Equal Employment
Opportunity Commission or similar state agency, Mr. Interno expressly waives the right to
receive any monetary damages as a result of such claim; (iv) that Mr. Interno has the right
to consult an attorney in connection with his decision to enter into this release; (v) that
Meridian has given Mr. Interno a period of at least 21 days to consider this release; (vi)
that Mr. Interno has the right to revoke this release within the seven day period after he
signs it; and (vii) that the release does not cover claims which might arise after the date
Mr. Interno signs it.”

5. Miscellaneous Items. (a) Meridian and Mr. Interno agree that Mr. Interno
may take with him as of the Effective Date, his office chair and office computer (a laptop
and a desk top computer) that Mr. Interno currently has in his office with Meridian
Bioscience Europe S.r.l. (“MBE”); and (b) Meridian and Mr. Interno agree that Mr. Interno
will retain a phone number and e-mail address at MBE for a period of twenty-one (21) months
from the Effective Date.

6. Non-Competition. As consideration for payments and obligations of Meridian
under this Agreement to Mr. Interno, during the term of the Professional Services Agreement,
and for a period of two (2) years from the termination or expiration of the Professional
Services Agreement, Mr. Interno covenants and agrees that:

(a) Mr. Interno shall not, directly or indirectly, engage in the developing,
manufacturing, or marketing of immunodiagnostic and molecular test kits, purified reagents,
related diagnostic products or other business conducted by Meridian or any of its
affiliates, nor, directly or indirectly, enter into any competition with Meridian or any of
its affiliates, in any location or jurisdiction in which Mr. Interno has conducted business
on behalf of Meridian or any of its Affiliates at any time;

(b) Mr. Interno shall not solicit, directly or indirectly, any of Meridian’s or any of
its affiliates’ customers, business contacts or other affiliates who
became known to Mr. Interno while he was employed or acted on behalf of Meridian or any
of its affiliates;

 

2

 

(c) Mr. Interno shall not solicit or hire any of Meridian’s or any of Meridian
affiliates’ employees, independent contractors or other contracted parties performing
services for Meridian or any of Meridian’s affiliates.

7. Confidentiality. Subject to the right to enforce the terms of this
Agreement, Mr. Interno agrees not to disclose the terms of this Agreement to any person or
entity without the written consent of Meridian, except to Mr. Interno’s immediate family
members, tax preparer, and legal counsel, provided they agree to honor this non-disclosure
provision, or where disclosure is required by law.

8. Contemporaneous Execution. This Agreement shall be executed simultaneously
with a Mutual Termination and Full Settlement between Mr. Interno, Meridian Bioscience
Europe S.r.l., an Italian corporation, Meridian Bioscience Europe S.A., a Belgian
corporation, Meridian Bioscience S.A., a Belgian corporation, and Meridian Bioscience B.V.,
a Netherland corporation.

9. Entire Agreement and Amendments. Meridian and Mr. Interno agree that this
Agreement, including the exhibits hereto, constitutes the entire agreement between them with
respect to the subject matter hereof, and that any and all prior discussions, negotiations,
agreements and understandings including, without limitation, any prior agreement between
Meridian and Mr. Interno are hereby superseded. The terms and provisions of this Agreement
shall not be changed, amended, waived, modified or terminated in any respect whatsoever
except by a written instrument executed by Meridian and Mr. Interno.

10. No Waiver of Rights. Neither any failure nor any delay on the part of
Meridian in exercising any right, power or privilege hereunder shall operate as a waiver
thereof on the part of Meridian nor shall a single or partial exercise thereof preclude any
other or further exercise or the exercise of any other right, power or privilege by
Meridian.

11. Notice. Any and all notices given or required to be given hereunder shall
be sent in accordance with Section 10 of Exhibit A attached hereto.

12. Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be deemed an original and all of which shall constitute
one and the same agreement.

13. Headings; Gender; Number. The headings contained in this Agreement are for
convenience only and shall not be construed as substantive provisions of this Agreement.
Words of any gender shall include any other gender, unless the context requires otherwise.
Singular words shall include the plural and plural words shall include the singular, unless
the context requires otherwise.

 

3

 

14. Governing Law; Jurisdiction. This Agreement shall be governed by the
internal substantive laws of the State of Ohio, USA, without reference to conflict of laws
principles. All claims, disputes, or lawsuits arising under or from this Agreement shall be
exclusively instituted in the state and federal courts situated in Hamilton County, Ohio,
U.S.A., and Meridian and Mr. Interno hereby unconditionally and irrevocably submit and
consent to the jurisdiction and venue of any such court for such purpose.

15. Change in Control. Upon the occurrence of a Change in Control as defined
in Sections 4.3 and 4.4 of the Meridian Bioscience, Inc. 2004 Equity Compensation Plan as
Amended and Restated through January 22, 2008, any remaining payments under the Professional
Services Agreement shall be accelerated and paid in a lump sum.

[Remainder of page is blank. Signature page follows.]

 

4

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year set
forth above.

	 	 	 	 	 	 	 	 	 
	WITNESSES:	 	Company:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	MERIDIAN BIOSCIENCE, INC.	 	 
	 
	 	 	 	 	 	 	 	 
	/s/ Fabio Rossella	 	By:	 	/s/ John A. Kraeutler	 	 
	 	 	 	 	 	 	 
	Fabio Rossella

	 	 	 	Name:
	 	John A. Kraeutler	 	 
	Witness for Interno

	 	 	 	Title:
	 	CEO	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	ANTONIO ALESSANDRO INTERNO:	 	 
	 
	 	 	 	 	 	 	 	 
	/s/ Torretta Simona	 	/s/ Antonio Alessandro Interno	 	 
	 	 	 	 	 
	Torretta Simona
	 	 	 	 	 	 	 	 
	Witness for Interno
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	/s/ Melissa Lueke
	 	 	 	 	 	 	 	 
	 

Melissa Lueke

	 	 	 	 	 	 	 	 
	Witness for Kraeutler
	 	 	 	 	 	 	 	 

 

5

 

EXHIBIT A

RESIGNATION LETTER

March 31, 2011

Meridian Bioscience, Inc.

3471 Riverhills Drive

Cincinnati, Ohio 45244

Attention: Mr. John A. Kraeutler

RE: Resignation

Gentlemen:

I hereby resign effective immediately from all of my official capacities as an officer of Meridian
Bioscience, Inc., and from all other capacities that I act on behalf of Meridian Bioscience, Inc.
up to this date.

	 	 	 	 	 
	 	Sincerely,

ANTONIO ALESSANDRO INTERNO

 	 
	 	/s/ Antonio Alessandro Interno
 	 

 

 

 

EXHIBIT B

PROFESSIONAL SERVICES AGREEMENT

THIS PROFESSIONAL SERVICES AGREEMENT (“the Agreement”) executed effective as of the 1st day of
April, 2011, is entered into by and between Meridian Bioscience, Inc., an Ohio corporation with a
principal place of business at 3471 Riverhills Drive, Cincinnati, Ohio 45244, USA (“Meridian”), and
Antonio Alessandro Interno, an Italian citizen residing at Via dei Pini 8, 20020 Arconate, Milan,
Italy (“Mr. Interno”).

WHEREAS, Meridian desires to build and promote brand awareness and equity within Africa, Europe,
the Middle East and Scandinavia; and

WHEREAS, Mr. Interno has the knowledge, experience and desire to assist Meridian in this capacity.

NOW THEREFORE, in reliance on the foregoing, and in consideration of the mutual covenants set forth
herein and other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, Meridian and Mr. Interno agree as follows:

	 	1.	 	Professional Services. Mr. Interno shall provide professional services to
Meridian, as an independent contractor, with the objective to build and promote brand
awareness and equity within Africa, Europe, the Middle East and Scandinavia, related to the
Meridian Bioscience trade name. Mr. Interno shall perform such services to, and on behalf
of, Meridian on a monthly basis, including, but not limited to, the following (“Services”):

	 	a.	 	Identifying and introducing key opinion leaders, hospitals,
laboratories, physicians and other healthcare diagnostic supply chain participants
with the objective of promoting the Meridian brand;

	 	b.	 	Alerting management of competitors at risk for possible intellectual
property infringement that could harm the Meridian brand;

	 	c.	 	Identifying potential product sourcing opportunities that could
complement the Meridian brand; and

	 	d.	 	Other similar activities with the objective of promoting the Meridian
brand.

Mr. Interno shall perform all Services under this Agreement outside the United States as an
“independent contractor” and not as an employee or agent of Meridian or any of Meridian’s
subsidiary companies. Mr. Interno is not authorized to assume or create any obligation or
responsibility, express or implied, on behalf of, or in the name of, Meridian or to bind
Meridian in any manner. For sake of clarity, Mr. Interno shall not be authorized to
negotiate or execute contracts or any type of business transaction on behalf of Meridian.
Mr. Interno warrants, represents and covenants that he shall provide the Services in good
faith and in a diligent, businesslike and professional manner.

 

2

 

	 	2.	 	Fees and Payments. Meridian shall pay Mr. Interno as full payment for Services
rendered by him hereunder, at a monthly rate of six-thousand five-hundred Euros (€6,500.00)
(“Professional Services Fee”). The Professional Services Fee shall be payable by Meridian
on the 15th calendar day of each month, provided that prior to the
10th calendar day of each month, Mr. Interno has submitted to Meridian an
invoice for that month. Mr. Interno shall submit his invoices to Meridian’s Chief
Financial Officer (CFO) or Chief Executive Officer (CEO) via e-mail or facsimile.

Meridian shall reimburse Mr. Interno for only pre-approved (by the CFO or CEO) out-of-pocket
costs that he may incur in his performance of his obligations under this Agreement. Such
reimbursement shall not exceed five thousand Euros (€5,000.00) in any calendar year.

	 	3.	 	Term. Subject to the provisions of this Section 3, the term of this Agreement
(the “Term”) shall commence on the date hereof and end on December 31, 2012, unless this
Agreement is terminated by mutual written agreement of the parties. Notwithstanding the
foregoing, this Agreement and all rights of Mr. Interno under this Agreement will terminate
(except as otherwise provided in this Section),

	 	a.	 	Upon the death of Mr. Interno;

	 	b.	 	Upon breach of any provision of this Agreement.

	 	4.	 	Authority and Indemnification of Meridian. Mr. Interno represents that he is
not restricted or prohibited in any manner from entering into this Agreement and performing
the duties for Meridian as herein provided. Mr. Interno shall indemnify and save harmless
Meridian from any damages, liabilities, actions, suits or other claims, and from reasonable
attorneys’ fees and costs incurred by Meridian in defending against same, should Mr.
Interno’s representations set forth in this Section 4 be challenged.

	 	5.	 	Severability. If any of the provisions of this Agreement are held to be
illegal, invalid or unenforceable in any respect, Meridian and Mr. Interno agree that such
term or provision shall be deemed to be modified to the extent necessary to permit its
enforcement to the maximum extent permitted by applicable law. If any of the provisions of
this Agreement are held to be illegal, invalid or unenforceable in any respect, the
remainder of this Agreement and all other provisions hereof shall not be affected thereby.

	 	6.	 	Parties Bound. This Agreement shall be binding upon and shall inure to the
benefit of the parties and their respective heirs, administrators, executors, legal
representatives, successors and permitted assigns; provided, however, that
Mr. Interno shall not assign any of Mr. Interno’s rights or delegate any of his duties
hereunder without the prior written consent of Meridian. Meridian shall not assign any of
its rights or delegate any of its duties hereunder to any person or entity without the
prior written consent of Mr. Interno.

 

3

 

	 	7.	 	Governing Law. This Agreement shall be governed by the internal substantive
laws of the State of Ohio, USA, without reference to conflict of laws principles. All
claims, disputes, or lawsuits arising under or from this Agreement shall be exclusively
instituted in the state and federal courts situated in Hamilton County, Ohio, U.S.A., and
Meridian and Mr. Interno hereby unconditionally and irrevocably submit and consent to the
jurisdiction and venue of any such court for such purpose.

	 	8.	 	Entire Agreement and Amendments. Meridian and Mr. Interno agree that this
Agreement constitutes the entire agreement between them with respect to the subject matter
hereof, and that any and all prior discussions, negotiations, agreements and understandings
including, without limitation, any prior agreement between Meridian and Mr. Interno are
hereby superseded. The terms and provisions of this Agreement shall not be changed,
amended, waived, modified or terminated in any respect whatsoever except by a written
instrument executed by Meridian and Mr. Interno.

	 	9.	 	No Waiver of Rights. Neither any failure nor any delay on the part of Meridian
in exercising any right, power or privilege hereunder shall operate as a waiver thereof on
the part of Meridian nor shall a single or partial exercise thereof preclude any other or
further exercise or the exercise of any other right, power or privilege by Meridian.

	 	10.	 	Notice. Any and all notices given or required to be given hereunder shall be
sent by personal delivery or by certified mail, return receipt requested, and shall
conclusively be deemed to have been received on the date such notice is delivered at the
address specified below (or such other address as may be specified in writing by the
parties hereof) or, in the case of certified mail, on the fifth (5th) business day
following the date on which it was mailed.

	 	 	 
	If to Meridian:

	 	MERIDIAN BIOSCIENCE, INC.
	 
	 

	 	3471 River Hills Drive
	 

	 	Cincinnati, Ohio 45244
	 

	 	Attention: John A. Kraeutler

If to Mr. Interno, at the address set forth on the first page hereof.

	 	11.	 	Counterparts. This Agreement may be executed in any number of counterparts,
each of which shall be deemed an original and all of which shall constitute one and the
same agreement.

	 	12.	 	Headings; Gender; Number. The headings contained in this Agreement are for
convenience only and shall not be construed as substantive provisions of this Agreement.
Words of any gender shall include any other gender, unless the context requires otherwise.
Singular words shall include the plural and plural words shall include the singular, unless
the context requires otherwise.

[Remainder of page is blank. Signature page follows.]

 

4

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year set
forth above.

	 	 	 	 	 	 	 	 	 
	WITNESSES:	 	Company:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	MERIDIAN BIOSCIENCE, INC.	 	 
	 
	 	 	 	 	 	 	 	 
	/s/ Melissa Lueke	 	By:	 	/s/ John A Kraeutler	 	 
	 	 	 	 	 	 	 
	Melissa Lueke

	 	 	 	Name:
	 	John A. Kraeutler	 	 
	 

	 	 	 	Title:
	 	CEO	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	ANTONIO ALESSANDRO INTERNO:	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	/s/ Antonio Alessandro Interno	 	 
	 	 	 	 	 

 

 

 

Between

Meridian Bioscience Europe S.r.l.

and

Meridian Bioscience Europe S.A.

and

Meridian Bioscience S.A.

and

Meridian Bioscience Europe B.V.

and

Mr. Antonio Alessandro Internò

Mutual termination of employment relationship and directorship

and full and general novation settlement

 

2

 

On 22/3, 2011, in Milan (Italy)

BETWEEN

Meridian Bioscience Europe S.r.l., an Italian corporation with registered office in
Villa Cortese (MI), Via Dell’Industria no. 7, represented by Mr. John A Kraeutler, in his
capacity as Director (hereinafter referred to as “MBE Italy”)

As the first party

- And -

Meridian Bioscience Europe S.A., a Belgian corporation with registered office in
Nivelles, Rue de l’Industrie no. 7 B-1400, represented by Mr. John A Kraeutler, in his capacity
as Director

As the second party

- And -

Meridian Bioscience S.A., a Belgian corporation with registered office in Nivelles, Rue
de l’Industrie no. 7 B-1400, represented by Mr. John A Kraeutler, in his capacity as Director;

As the third party

- And -

Meridian Bioscience B.V., a Dutch corporation with registered office in Haiderheiweg 6,
5282 SN Boxtel, represented by Mr. John A Kraeutler as an authorized representative;

As the fourth party

- And -

Mr. Antonio Alessandro Internò, resident in 20020 Arconate (MI), Via dei Pini, no. 8,
(hereinafter referred to as the “Executive” or the “Managing Director”)

As the fifth party

RECITALS

	 	A.	 	With the Board of Directors’ resolution dated September 7, 1994 Mr. Internò was
appointed Managing Director of MBE Italy for an indefinite period of time;

	 	B.	 	On December 1, 2001, Mr. Internò was hired by MBE Italy as an Executive under the
National Collective Labour Agreement for Executives of the Trade sector (hereinafter
referred to as “CBA”);

 

3

 

	 	C.	 	In addition, Mr. Internò holds the following corporate offices: (i) Chairman of the
Board of Directors and Managing Director of Meridian Bioscience Europe S.A.; (ii) Chairman
of the Board of Directors and Managing Director of Meridian Bioscience S.A.; (iii) Chairman
of the Board of Directors and Managing Director of Meridian Bioscience Europe B.V.;

	 	D.	 	in the spirit of co-operation which has always characterised their relationships, the
parties are willing to settle amicably, once for all, any past or future questions
regarding the execution and the termination of both the employment relationship with MBE
Italy and all the above mentioned directorships, within a sole and general and full
settlement.

Termination of the employment relationship and directorship

and general and full settlement

	 	1.	 	Recitals

	 	(1)	 	The above Recitals are part of this agreement.

	 	2.	 	Termination by mutual consent of the employment relationship with MBE Italy

	 	(1)	 	MBE Italy proposed to the Executive to terminate his employment contract by
mutual consent and offered him a leaving incentive.

	 	(2)	 	The Executive accepted the above proposal at the conditions set forth
hereunder.

	 	(3)	 	The employment contract between Mr. Internò and MBE Italy is deemed terminated
by mutual consent effective as of April 1, 2011, with termination on the same date of
any mutual obligations deriving from the law and/or from the contract.

	 	(4)	 	Mr. Internò shall return, within five (5) days from April 1, 2011, all the
company items and goods currently in his possession.

	 
	 	(5)	 	Mr. Internò shall receive:

	 	a.	 	the fixed salary until the date of termination of the employment
relationship;

	 	b.	 	the supplementary monthly salary instalments accrued
(13th and 14th month provisions) until the actual
termination date;

	 	c.	 	the indemnity in lieu of accrued and unused holidays and leaves;

	 	d.	 	he severance payment (“Trattamento di Fine Rapporto”), if not
transferred to third parties.

	 	(6)	 	All other benefits shall cease as of April 1, 2011.

 

4

 

	 	3.	 	Leaving incentive

	 	(1)	 	In addition to the amounts provided under clause 2.(5), MBE Italy shall pay
the Executive a gross amount of EUR 550.000,00 as leaving incentive and as
compensation for the termination by mutual consent of the employment relationship
indicated under point B. of the Recitals. It is agreed that such payment is
conditioned to the formalization of the settlement agreement as provided under clause
7.(1).

	 	(2)	 	The amount specified under clause 3. (1) is not subject to any social
contribution payments in accordance with Section 12 of Italian Law no. 153 of 30 April
1969, as amended by Section 6 of Law Decree no. 314 of 2 September 1997. This amount
shall be subject to personal income tax (i.e. “Imposta sul reddito delle persone
fisiche” IRPEF), as calculated according to the criteria provided by Sections 17 and
19 of Presidential Decree no. 917 of 22 December 1986 (TUIR). Payment of the gross
amount specified under clause 3.(1) shall be made to Executive after deducting the
withholding taxes.

	 	4.	 	Termination of the corporate offices

	 	(1)	 	Mr. Internò undertakes to renounce and resign with immediate effect from his
office of Director and Managing Director of MBE Italy, by signing and sending, by
March 31, 2011 and no later, the relevant resignation letters attached hereto as
Exhibit A to the members of Board of Directors and to the Chairman of the Board of
Statutory Auditors. In any case, the Executive agrees that this agreement represents
the renouncement of his offices with immediate effect according to law and to Section
2385 of the Italian Civil Code.

	 	(2)	 	Furthermore, Mr. Internò undertakes to renounce and resign with immediate
effect from his corporate offices indicated under point C of the Recitals as of April
1, 2011, by signing and sending, by March 31, 2011 and no later, the relevant
resignation letters attached hereto as Exhibits B, C and D to the competent corporate
boards as provided by the local laws. In any case, Mr. Internò agrees that this
agreement represents the renouncement of his corporate offices held at all the
aforementioned companies with immediate effect, according to the local laws of the
countries where these companies are located.

 

5

 

	 	(3)	 	Moreover, Mr. Internò undertakes to hand over to the person who will be
indicated, by and not later than April 6, 2011, all and any information and
description relating to MBE Italy and/or to any other company of the Group, such as
technical, organizational, financial or commercial information as well as any other
information or corporate secret relating to such companies that Mr. Internò has
learned during his employment and/or corporate relationships. By way of example and
without limitation, Mr. Internò undertakes to disclose, before the above mentioned
term, to the person who will be indicated any information concerning trade
negotiations and any talks pending or potential with actual and/or prospective
customers and/or with any third party, models or technical solutions, organizational
practices, company and Group plans, names of customers and suppliers, development and
investment plans as well as any other information relating to the activity carried out
by any company of the Group that he has been informed during the employment and/or the
corporate relationships hereunder. All of the corporate documents, of any kind,
including hardware and software, personal notes on acts or facts concerning the
employment and the corporate relationships hereunder, plans, corporate production
processes, methods, know-how, trade secrets, schemes, technologies, reports,
researches, correspondence and personal notes on acts or facts relating to the
Executive’s activity, shall be handed over by the aforesaid term to the person who
will be indicated as above.

	 	5.	 	Non competition

	 	(1)	 	In consideration of the directorships held by Mr. Internò at MBE Italy, it is
provided that he shall remain subject to the non-competition agreement executed on
February 19, 1991 and to the terms and conditions set forth therein for a period of
five years starting from April 1, 2011.

	 	6.	 	Waivers

	 	(1)	 	In the context of a general novation settlement pursuant to Sections 1965 and
1975 of the Italian Civil Code, Mr. Internò waives to any claim against Meridian
Bioscience Europe S.r.l., as well as to any claim towards any other parent company,
subsidiary, or controlled company or any other company of the Meridian Group, in Italy
or abroad, for any right arising from or related to the employment relationship
indicated under point B. of the Recitals and its termination, including any right
provided by law and by the CBA. By way of example, but not limited to, the Executive
waives all claims for different seniority, salary differences and outstanding
remuneration of any kind (including bonuses and rights related to
and deriving from any incentive plan that the Executive participated in), withholding
taxes, any kind of expenses refund, different calculation of salary items, paid in any
form, in relation to legal and contractual institutes. Furthermore the Executive waives
any indemnities as well as any claims for damages including tort and/or non-material
damages according to Sections 2043, 2059, 2087, 2103 and 2116, second paragraph, of the
Italian Civil Code.

 

6

 

	 	(2)	 	Moreover, still within the aforesaid context of general and full settlement
pursuant to Sections 1965 and 1975 of the Italian Civil Code, Mr. Internò waives to
claim any potential right that may arise out of or be related to:

	 	(i)	 	the execution and the termination of the directorships indicated
under points A. of the Recitals, against MBE Italy and/or against any other
company connected to or controlled by such company, as well as against any other
company of the Meridian Group anywhere located or incorporated;

	 	(ii)	 	the execution and the termination of the directorships indicated
under points C. of the Recitals, against the respective companies in which the
corporate offices therein mentioned are held by Mr. Internò and/or against any
other company connected to or controlled by those companies, as well as against
any other company of the Meridian Group anywhere located or incorporated.

	 	(3)	 	The waivers under clause 6.(2) include, but are not limited to, any different
qualification of the relevant corporate offices, any right concerning outstanding
remuneration of any kind (including eventual bonuses and rights related to and/or
deriving from any incentive plan that Mr. Internò participated in), withholding taxes,
any kind of expenses refund, any other right deriving from law. Mr. Internò also waives
any indemnities and any claims for damages including tort and/or non-material damages
according to sections 2043, 2059 and 2087 of the Italian Civil Code, as well as any
possible remunerations, indemnities, compensations and claim relating to or deriving
from the corporate offices indicated under point A. of the Recitals, including the
rights deriving from Sections 2383, paragraph 3, and 2389 of the Italian Civil Code.

	 	(4)	 	Furthermore, Mr. Internò expressly represents and warrants that as at the date
of execution of this agreement he is not aware of any potential claim, civil and/or
criminal proceedings against him or any of the undersigned companies that may arise
from or anyhow be connected with the performance of the directorships and/or the
employment relationships specified under points A., B. and C. of the Recitals.

 

7

 

	 	(5)	 	Against the waivers indicated under clauses 6.(1), 6.(2) and 6.(3), MBE Italy,
Meridian Bioscience Europe S.A., Meridian Bioscience SA and Meridian Bioscience B.V.
accept such waivers and expressly waive any action and/or claim against Mr. Internò in
relation to any responsibility connected to his corporate offices of Managing
Director/Chairman of the Board of Directors/legal representative of the aforementioned
corporations. Moreover, the above corporations represent that they have no further
claim against Mr. Internò in connection with the above corporate offices, save for any
eventual damages deriving to the corporations from any act and/or deed executed by Mr.
Internò with gross negligence or willful misconduct and save for any illegal act
committed by Mr. Internò in violation of Italian laws and/or US Foreign Corrupt
Practices Act and/or US Export Control Laws.

	 	(6)	 	In addition, the corporations MBE Italy, Meridian Bioscience Europe S.A.,
Meridian Bioscience S.A. and Meridian Bioscience B.V. undertake to keep Mr. Internò
unharmed and guaranteed against any possible negative economic consequence which may
arise in connection with any claim and/or demand and/or dispute brought by third
parties against Mr. Internò in his capacity as Managing Director/Chairman of the Board
of Directors/legal representative of the aforementioned corporations, save for any act
and/or deed executed by Mr. Internò with gross negligence or willful misconduct and
except for any illegal act committed by Mr. Internò in violation of Italian laws and/or
US Foreign Corrupt Practices Act and/or US Export Control Laws.

	 	(7)	 	More specifically, MBE Italy hereby expressly represents to keep Mr. Internò
unharmed and indemnified against any present or future claim and/or demand and/or
dispute which may involve Mr. Internò in his capacity as Managing Director/Chairman of
the Board of Directors/legal representative/Executive of MBE Italy, save for any act
and/or deed executed by Mr. Internò with gross negligence or willful misconduct and
except for any illegal act committed by Mr. Internò in violation of Italian laws
and/or US Foreign Corrupt Practices Act and/or US Export Control Laws.

	 	(8)	 	The corporations MBE Italy, Meridian Bioscience Europe S.A,. Meridian
Bioscience SA and Meridian Bioscience BV undertake to bear the costs of any possible
fine and/or penalty, which may be inflicted to Mr. Internò due to the personal and/or
joint responsibility with the aforementioned corporations, for facts
relating to or connected with his corporate offices of Managing Director/Chairman of
the Board of Directors/legal representative/Executive of the same corporations, save
for any act and/or deed executed by Mr. Internò with gross negligence or willful
misconduct and except for any illegal act committed by Mr. Internò in violation of
Italian laws and/or US Foreign Corrupt Practices Act and/or US Export Control Laws.

 

8

 

	 	(9)	 	The parties declare that with execution of this settlement, and the
fulfillment of the same, they do not have any further claim deriving from the
execution and the termination of the employment relationship and/or any directorship
or corporate office mentioned in this agreement

	 	7.	 	Settlement

	 	(1)	 	The payment of the amounts provided for in clause 3.(1) shall be made on the
condition that Mr. Internò signs, in front of one of the offices indicated by Sections
410 and 411 of the Italian Civil Procedure Code, an additional settlement agreement
with MBE Italy, that shall have the exact same contents of this agreement within about
60 days from today subject to the availability of the offices.

	 	8.	 	Terms of payment

	 	(1)	 	The payment of the amount set forth under clause 2.(5) shall be made with the
usual terms and methods.

	 	(2)	 	The payment of the gross amount sets forth under clause 3.(1) shall be made,
after deducting withholding taxes as provided by Italian law, by wire transfer to the
bank account of Mr. Internò already used by MBE Italy to deposit his employment salary,
within maximum 60 days from the termination of the employment relationship and in any
case after the formalization of the settlement agreement as provided under clause
7.(1).

	 	 	 	 	 
	Mr. Antonio Alessandro Internò

	 	/s/ Antonio Alessandro Internò
 

	 	 
	 
	 	 	 	 
	Meridian Bioscience Europe S.r.l.

	 	/s/ John A. Kraeutler
 

	 	 
	 
	 	 	 	 
	Meridian Bioscience Europe S.A.

	 	/s/ John A. Kraeutler
 

	 	 
	 
	 	 	 	 
	Meridian Bioscience S.A.

	 	/s/ John A. Kraeutler
 

	 	 
	 
	 	 	 	 
	Meridian Bioscience Europe B.V.

	 	/s/ John A. Kraeutler
 

	 	 

 

9

 

Exhibit A

Milan, March 31, 2011

To the kind attention of the Board of Directors

Messrs. William J. Motto and John A. Kraeutler

Meridian Bioscience Europe S.r.l.

Via dell’Industria, no. 7

20020 — Villa Cortese (MI)

Registered letter

Anticipated by Fax on no. 513.271.3762

To the kind attention of the Chairman of the Board of Auditors

Mr. Aldo D’Aula

Meridian Bioscience Europe S.r.l.

Via dell’Industria, no. 7

20020 — Villa Cortese (MI)

Registered letter

Anticipated by Fax on no. 0331.433616

Resignation

I, the undersigned, Antonio Alessandro Internò, hereby resign from the office of
Director and Managing Director of Meridian Bioscience Europe S.r.l. with irrevocable and
definitive effect as of April 1, 2011.

Moreover, I hereby state to have nothing to claim against the Company in connection with
the above mentioned offices, as compensation, reimbursement of expenses and/or for any
further possible title, reason or cause.

Yours sincerely

	 	 	 	 	 
	 

	 	Antonio Alessandro Internò	 	 
	 
	 	 	 	 
	 

	 	/s/ Antonio Alessandro Internò	 	 
	 

	 	 

	 	 

 

10

 

Exhibit B

Milan, March 31, 2011

To the kind attention of the Board of Directors

Meridian Bioscience Europe S.A.

Rue de l’Industrie no. 7 B

Nivelles

Registered letter

Resignation

Dear Mr Kraeutler,

Hereby I would like to inform you that I am resigning from my mandate as director and managing
director of Meridian Bioscience Europe SA (RPR 0408.081.968), and this as of 31 March 2011.

As there are currently only two directors, I will assist with all formalities and sign all required
documents in order to foresee in my replacement.

I can confirm that director fees remuneration has been paid to me through the period ending 31
March 2011.

Moreover, I hereby state to have nothing to claim against the Company in connection with the above
mentioned offices, as compensation, reimbursement of expenses and/or for any further possible
title, reason or cause.

Yours sincerely,

	 	 	 	 	 
	 

	 	Antonio Alessandro Internò	 	 
	 
	 	 	 	 
	 

	 	/s/ Antonio Alessandro Internò	 	 
	 

	 	 

	 	 

 

11

 

Exhibit C

Milan, March 31, 2011

To the kind attention of the Board of Directors

Meridian Bioscience S.A.

Rue de l’Industrie no. 7 B

Nivelles

Registered letter

Resignation

Dear Mr Kraeutler,

Hereby I would like to inform you that I am resigning from my mandate as director and managing
director of Meridian Bioscience SA (RPR 0450.405.345), and this as of 31 March 2011.

As there are currently only two directors, I will assist with all formalities and sign all required
documents in order to foresee in my replacement.

I can confirm that director fees remuneration has been paid to me through the period ending 31
March 2011. Moreover I hereby state to have nothing to claim against the Company in connection
with the above mentioned offices, as compensation, reimbursement of expenses and/or for any further
possible title, reason or cause.

Yours sincerely,

	 	 	 	 	 
	 

	 	Antonio Alessandro Internò	 	 
	 
	 	 	 	 
	 

	 	/s/ Antonio Alessandro Internò	 	 
	 

	 	 

	 	 

 

12

 

Exhibit D

Milan, March 31, 2011

Resignation statement

I, the undersigned, Antonio Alessandro Internò, hereby declare:

	(i)	 	that the undersigned is a member of the Management Board of Meridian Bioscience Europe B.V.,
a private limited liability company (besloten vennootschap met beperkte aansprakelijkheid)
under Dutch law, having its registered office at Boxtel (the Netherlands) and having its
correspondence address at Halderheiweg 6, 5282 SN Boxtel (the Netherlands), (hereinafter: the
“Company”);

	(ii)	 	to resign as a member of the Management Board of the Company with effect as from 31 March
2011;

	(iii)	 	not to have and that he will not have as per his resignation becoming effective any claim
against the Company relating to his position as a member of the Management Board of the
Company.

	 	 	 	 	 
	 

	 	Antonio Alessandro Internò	 	 
	 
	 	 	 	 
	 

	 	/s/ Antonio Alessandro Internò	 	 
	 

	 	 

	 	 

 

13

 

Between

Meridian Bioscience Europe S.r.l.

and

Meridian Bioscience, Inc.

and

Mr. Antonio Alessandro Internò

Voluntary set-off agreement ex Article 1252 of Italian Civil Code

 

14

 

On 18 Aprile, 2011 in Milan, Italy

BETWEEN

Meridian Bioscience Europe S.r.l., an Italian corporation with registered office in
Villa Cortese (MI), Via Dell’Industria no. 7, represented by Mr. John A Kraeutler, in his
capacity as Director (hereinafter referred to as “MBE Italy”)

As the first party

- And -

Meridian Bioscience, Inc., a US corporation with a principal place of business at 3471
Riverhills Drive, Cincinnati, Ohio (USA), represented by Mr. John A Kraeutler, in his capacity
as Director (hereinafter referred to as “Meridian USA”)

As the second party

- And -

Mr. Antonio Alessandro Internò, resident in Arconate (MI), Via dei Pini, no. 8,
(hereinafter referred to as the “Executive”)

As the third party

RECITALS

	 	A.	 	Mr. Internò has been an Executive of Meridian Bioscience Europe S.r.l., a company
belonging to Meridian Group, since December 1 2001 until April 1, 2011;

	 	B.	 	during his employment relationship with MBE Italy, Mr. Internò has participated to the
Equity Plan “2004 Equity Compensation Plan as Amended and Restated trough January 22,
2008”, approved by Meridian USA on 2004 and afterwards amended on January 22, 2008;

	 	C.	 	as per the provisions of such Equity Plan, the following stock units have been
assigned to Mr. Internò:

	 	(i)	 	no. 7,500 “restricted stock units”, awarded on November 12, 2009, which have
became fully vested upon the termination of the employment relationship of Mr. Internò
with MBE Italy;

	 	(ii)	 	no. 7,500 “restricted stock units”, awarded on November 11, 2010, which have
became fully vested upon the termination of the employment relationship of Mr. Internò
with MBE Italy;

 

15

 

	 	(iii)	 	no. 7,500 “performance-based stock units”, awarded on November 11, 2010,
which will become fully vested when the actual earnings of Meridian USA will be
released to the public indicatively on November 2011, upon condition that the net
earnings of Meridian USA will exceed 33,400,000 US dollars;

	 	D.	 	the employment relationship between MBE Italy and the Executive is terminated by
mutual consent by means of the settlement agreement executed between the parties on March
22, 2011;

	 	E.	 	within such settlement agreement MBE Italy has undertaken to pay to Mr. Internò, on
top of the normal end-of-service accruals, an amount as leaving incentive and as
compensation for the termination of the employment relationship equal to gross Euro
550,000 (fivehundrenfitythousand/00) by and no later than 60 days from the termination of
the employment relationship and anyhow on condition that the settlement agreement will
have been formalized before one of the offices indicated by Sections 410 and 411 of
Italian Civil Procedure Code;

	 	F.	 	the parties have not yet formalized and executed the settlement agreement mentioned
under point E. above and therefore MBE Italy has not yet paid to the Executive the
aforesaid amount as leaving incentive and as compensation for the termination of the
employment relationship.

NOW THEREFORE

In reliance of the foregoing, the parties agree as follows.

	 	1.	 	Recitals

	 	(1)	 	The above Recitals are part of this agreement.

	 	2.	 	Set-off agreement

	 	(1)	 	MBE Italy and Meridian USA hereby states that the withholding taxes that shall
be collected on the counter value of the shares that will be issued on the basis of
the 15,000 “restricted stock units” mentioned under points C.(i) and C.(ii) of the
Recitals, reckoned as at April 1 2011, is equal to Euro 108,914.97
(onehundredeightthousandninehundredfourteen/97)

 

16

 

	 	(2)	 	Mr. Internò hereby acknowledges the correctness of such amount and expressly
agrees that the amount of Euro 108,914.97
(onehundredeightthousandninehundredfourteen/97) shall be offset, pursuant to Article
1252 of Italian Civil Code, against the credit claimed by the Executive from MBE Italy
and thus that such amount shall be deducted from the net amount equivalent to the
gross amount of Euro 550,000
(fivehundredfiftythousand/00) after tax, payable to the Executive by MBE Italy as
provided for by the settlement agreement executed on March 22, 2011.

	 	 	 	 	 
	Mr. Antonio Alessandro Internò

	 	/s/ Antonio Alessandro Internò	 	 
	 

	 	 

	 	 
	 
	 	 	 	 
	Meridian Bioscience Europe S.r.l.

	 	/s/ Fabio Rossella	 	 
	 

	 	 

	 	 
	 
	 	 	 	 
	Meridian Bioscience Inc.

	 	/s/ John A. Kraeutler	 	 
	 

	 	 

	 	 

 

17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00189-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00189-of-00352.parquet"}]]